InsiderSignal.AI

InsiderSignal.ai

DGX - Quest Diagnostics Inc

Insider Sale by Plewman Patrick (SVP for Diagnostic Services)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Plewman Patrick, serving as SVP for Diagnostic Services at Quest Diagnostics Inc (DGX), sold 410 shares at $207.73 per share, for a total transaction value of $85,169.00. Following this transaction, Plewman Patrick now holds 15,198 shares of DGX.

This sale represents a 3.00% decrease in Plewman Patrick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Quest Diagnostics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Plewman Patrick

SVP for Diagnostic Services

Patrick Plewman is Senior Vice President for Diagnostic Services at Quest Diagnostics (NYSE:DGX), where he is responsible for growing a portfolio of data-driven analytics and serves as a member of the company's Executive Leadership Team[[5]](https://ir.questdiagnostics.com/governance/management-team/default.aspx). In this capacity, he oversees diagnostic services operations for the world's leading provider of diagnostic information services[[3]](https://ir.questdiagnostics.com/financial-info/financial-tearsheet/default.aspx). Recent insider trading activity shows Plewman sold 958 shares of Quest Diagnostics stock on February 19th at $204.83 per share, totaling approximately $196,227, while also acquiring 1,952 shares through a restricted stock unit award and receiving a grant of 9,009 non-qualified stock options on February 18th[[1]](https://www.investing.com/news/insider-trading-news/plewman-patrick-quest-diagnostics-svp-sells-196k-in-dgx-stock-93CH-4517444). Following these transactions, Plewman directly owns 15,838 shares of the company[[1]](https://www.investing.com/news/insider-trading-news/plewman-patrick-quest-diagnostics-svp-sells-196k-in-dgx-stock-93CH-4517444). Plewman's background and educational credentials are not detailed in available public records, though his executive position reflects significant responsibility within Quest Diagnostics' operations. The company, which maintains a market capitalization of $22.3 billion, recently reported strong fourth-quarter 2025 results with earnings per share of $2.42 and revenue of $2.81 billion, both exceeding analyst expectations[[1]](https://www.investing.com/news/insider-trading-news/plewman-patrick-quest-diagnostics-svp-sells-196k-in-dgx-stock-93CH-4517444). Plewman's continued investment in company stock through equity grants and his substantial shareholdings indicate confidence in the organization's long-term strategic direction[[1]](https://www.investing.com/news/insider-trading-news/plewman-patrick-quest-diagnostics-svp-sells-196k-in-dgx-stock-93CH-4517444).

View full insider profile →

Trade Price

$207.73

Quantity

410

Total Value

$85,169.00

Shares Owned

15,198

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

About Quest Diagnostics Inc

Company Overview

No company information available
View news mentioning DGX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4496957

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime